Blair William & Co/Il’s Abbott Laboratories Position
Does Blair William & Co/Il own Abbott Laboratories (ABT)? Yes — 1.33M shares worth $136M (+0.39% of its 13F portfolio) as of Q1 2026, down from 1.58M shares the prior filed quarter.
Position Value
$136M
Q1 2026
Shares
1.33M
% of Portfolio
+0.39%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.33M | $136M | +0.39% |
| Q4 2025 | 1.58M | $198M | +0.53% |
| Q3 2025 | 1.60M | $214M | +0.57% |
| Q2 2025 | 1.60M | $218M | +0.61% |
| Q1 2025 | 1.58M | $209M | +0.63% |
| Q4 2024 | 1.57M | $178M | +0.52% |
| Q3 2024 | 1.60M | $182M | +0.54% |
| Q2 2024 | 1.75M | $182M | +0.56% |
| Q1 2024 | 1.77M | $202M | +0.63% |
| Q4 2023 | 1.74M | $192M | +0.65% |
| Q3 2023 | 1.71M | $166M | +0.64% |
| Q2 2023 | 1.84M | $201M | +0.74% |
| Q1 2023 | 1.86M | $189M | +0.75% |
| Q4 2022 | 1.94M | $213M | +0.92% |
| Q3 2022 | 1.87M | $180M | +0.83% |
| Q2 2022 | 1.84M | $200M | +0.89% |
| Q1 2022 | 1.87M | $221M | +0.77% |
| Q4 2021 | 1.90M | $268M | +0.84% |
| Q3 2021 | 1.82M | $215M | +0.73% |
| Q2 2021 | 1.77M | $205M | +0.71% |
| Q1 2021 | 1.70M | $203M | +0.77% |
| Q4 2020 | 1.79M | $196M | +0.72% |
| Q3 2020 | 1.67M | $182M | +0.77% |
| Q2 2020 | 1.53M | $140M | +0.67% |
| Q1 2020 | 1.38M | $109M | +0.68% |
| Q4 2019 | 1.39M | $120M | +0.62% |
| Q3 2019 | 1.33M | $111M | +0.64% |
| Q2 2019 | 1.32M | $111M | +0.63% |
| Q1 2019 | 1.29M | $103M | +0.63% |
| Q4 2018 | 1.20M | $87M | +0.63% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Blair William & Co/Il’s full portfolio or all institutional holders of ABT.